Quanticate has developed automated systems using the latest versions of Phoenix WinNonlin® and SAS® to deliver high quality pharmacokinetic (PK) reports, along with additional PK, pharmacodynamic (PD), and PK/PD services, including:
All work is performed in accordance with relevant GCP, ICH, EMEA, and FDA guidelines.
One of the main reasons for drug attrition in clinical development is poor pharmacokinetics (PK) [Kola and J. Landis, Nature Reviews Drug Discovery, 3, 711-715 (2004)]. To reduce this risk, it is essential to fully investigate the pharmacokinetics of a new drug during each stage of development.
Learn more about the benefits of using a Pharmacokinetics Handover Document in PK Studies, download the paper now!